Cambrex Corporation complete New Top Price of 12 months - NYSE:CBM
Cambrex Corporation (NYSE:CBM) is a life sciences company that provides products and services for the development and commercialization of new and generic therapeutics. Cambrex Corporation achieved its new 52 week high price of $7.99 where it was opened at $7.41 UP 0.51 points or +6.90% by closing at $7.90.
Cambrex Corporation Accomplished Record New Price of 52 Weeks - NYSE:CBM
Cambrex Corporation (NYSE:CBM) is a life sciences company that provides products and services for the development and commercialization of new and generic therapeutics. The Company primarily supplies its products and services worldwide to pharmaceutical companies and generic drug companies.
Cambrex Corporation price grew and Hit 12 months New High - NYSE:CBM
(SKH, GRHU, NR, PWRM, CBM) Market News From PennyOmega.com
GreenHouse Holdings, Inc. (OTCQB:GRHU) a leading provider of energy efficiency solutions and sustainable infrastructure products, announced that it has been engaged to implement Southern California Edison's (SCE) Automated Demand Response (Auto-DR) program for two industrial customers. The customers are Apogee Containers, Inc. and MGE UPS, LLC.
DrStockPick.com Offers Updates On CPT, CBM, DTSL and CPN.
PROT.OB, CPN, CBM, CPT Stock Market Report from PennyOtcStock.com
Proteonomix, Inc., (OTCBB:PROT.OB) a biotechnology company focused on developing therapeutics based upon human cells and their derivatives, announced further developments with its Joint Venture Company, XGEN Medical LLC towards implementing operations in the United Arab Emirates (U.A.E.).